Markets
NVDA and other datacenter stocks slump, as construction continues to cool
(Eli Hiller/Getty Images)

AI data center trade dented in the first trading session of September

The hyperscalers writing the checks for AI data centers are the heaviest weight on stocks Tuesday, but others hitched to the investment boom are falling too.

9/2/25 2:10PM

Stocks hitched to the data center boom were key contributors to the market slump Tuesday, with Nvidia and the so-called hyperscalers — Amazon, Microsoft, Meta, and Alphabet — among the biggest contributors to the downturn in the S&P 500.

But the weakness in the AI trade goes beyond those companies writing the sizable checks needed for AI data centers, stretching up and down the data center value chain.

Shares of semiconductor equipment makers like ASML are down, as are top chip foundries like TSMC. Non-Nvidia chip stocks like Advanced Micro Devices, Lam Research, and Qualcomm are slipping, as are AI energy plays like Talen Energy, NRG, and GE Vernova. Finally, makers of the wires, servers, and racks — like Cisco, Vertiv Holdings, and Dell — that are eventually supposed to fill these hangar-like structures are also dropping.

The cause of Tuesday’s slump? Tough to say.

True, the Trump administration’s decision to strip TSMC of its ability to ship gear to its manufacturing base on the Chinese mainland has injected some uncertainty into the global tech sector. But TSMC is holding up better than most of these aforementioned stocks!

The breadth of the sell-off seems more along the lines of a momentary (and understandable) crack in confidence that sometimes emerges in even the most unanimous bets on Wall Street. That would include the staunch belief among investors, traders, and companies that AI is going to fundamentally reshape the US economy, creating untold riches for companies in the industry.

Moments of doubt make some sense. After all, while AI has shown a lot of promise, for the moment it remains more of a market phenomenon than an economic one. That is, despite its outsized role in the stock market, we haven’t seen the explosion of profits and productivity that would be needed to justify all this investment.

“The AI boom has had less of an impact on the economy than widely believed,” analysts at BCA Research wrote last month. “This may eventually change, but the risk is that investors grow impatient before it does.”

Hedge fund manager and market-making maven Ken Griffin seems to agree, telling Barron’s recently, “There is one salient issue in the equity market now: how much of the hype of AI will translate into the reality of a more productive, more prosperous future?"

Nobody, not even Ken Griffin, knows. But in the meantime, the bet continues to build. The latest data on US construction spending released on Tuesday (chart above) shows that the boom, while slowing a bit, is still very much alive.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.